Detalhe da pesquisa
1.
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production.
J Immunol
; 210(8): 1108-1122, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881874